Gaceta Mexicana de Oncología

Permanyer

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Gaceta Mexicana de Oncología is an open-access journal published by Permanyer in Mexico, publishing in spanish and english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 40 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Permanyer
ISSN
1665-9201 · 2565-005X
Country
Mexico
Languages
spanish, english
Access
Open access
Articles in DOAJ
256
Declared review time
40 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2021-05-01
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
40 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

256

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

40weeks

Works in OpenAlex

1134

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

11

i10-index

12

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2021-05-01
Added to DOAJ
2021-05-01
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Peer-review policy
View policy
Identity & continuity2
Alternate titles
GAMO
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Childhood Cancer Survivors' Quality of Life
  • Cancer Treatment and Pharmacology
Show all subjects (50)
  • Cancer Treatment and Pharmacology
  • Childhood Cancer Survivors' Quality of Life
  • Ethics and bioethics in healthcare
  • Ethics and bioethics in healthcare
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Neuroblastoma Research and Treatments
  • Neuroblastoma Research and Treatments
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
  • Health and Medical Education
  • BRCA gene mutations in cancer
  • Health and Medical Education
  • BRCA gene mutations in cancer
  • Testicular diseases and treatments
  • Testicular diseases and treatments
  • Palliative and Oncologic Care
  • Women's cancer prevention and management
  • Women's cancer prevention and management
  • Palliative and Oncologic Care
  • Intraperitoneal and Appendiceal Malignancies
  • Intraperitoneal and Appendiceal Malignancies
  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Nursing care and research
  • Lymphoma Diagnosis and Treatment
  • Palliative Care and End-of-Life Issues
  • Lung Cancer Research Studies
  • Bone Tumor Diagnosis and Treatments
  • Global Cancer Incidence and Screening
  • Lymphoma Diagnosis and Treatment
  • Palliative Care and End-of-Life Issues
  • Global Cancer Incidence and Screening
  • Nursing care and research
  • Lung Cancer Research Studies
  • Bone Tumor Diagnosis and Treatments
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment

Keywords (DOAJ)

  • cancer
  • oncology
  • medicine
  • radiotherapy
  • surgery
  • metastasis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: